Previous Page  9 / 9
Information
Show Menu
Previous Page 9 / 9
Page Background

Volume 7, Issue 6 (Suppl)

J Gastrointest Dig Syst, an open access journal

ISSN: 2161-069X

Page 37

December 07-08, 2017 Madrid, Spain

&

13

th

International Conference on Clinical Gastroenterology & Hepatology

2

nd

International Conference on Digestive Diseases

CO-ORGANIZED EVENT

Translational study to understand the role of gut microbiome and gut-brain axis in modeling

neurological disorders to evaluate recent treatment options: Special reference to autism

T

ranslational medicine concentrates on the interface between experimental basic science on animal models of chronic

diseases and clinical medicine. It aims to “translate” knowledge and mechanisms clarified by basic research into new

approaches for early diagnosis and the treatment of different diseases. Translation in the reverse direction is also highly

pertinent, namely the translation of clinical observations into novel research and treatment strategies. The gastrointestinal

microbiota has been linked to several important neurological diseases such as Alzheimer’s, Parkinson’s, and neurodevelopmental

disorders including autism spectrum disorders (ASD). Exposures to environmental toxins are now thought to contribute to

the development of these diseases. Progress in understanding and treating brain diseases will require translational research

efforts to transfer knowledge through successive fields of research from basic scientific discovery to public health impact.

With special reference to autism, a developmentally abnormal gut microbiota may in turn affect both the gut-brain axis

and brain development and contribute to the etiology of this disorder. Propionic acid (PA) found as a metabolic product of

propionibacteria has been reported to mimic/ mediate the neurotoxic effects of autism. Results from animal studies may guide

investigations on human populations toward identifying environmental contaminants that produce or drugs that protect from

neurotoxicity. Propionic acid (PA) either orally administered or biologically induced in clindamycin or ampicillin-treated rat

pups will be used to induce persistent autistic features and to ascertain the role of overgrowth of propionic acid producing

bacteria in inducing autistic features in rodent models. In intoxicated rats, a panel of biomarkers were investigated and

compared to healthy untreated rat pups. These biomarkers were selected to measure DNA damage, glutamate excitotoxicity,

oxidative stress, neurochemistry, mitochondrial dysfunction, and neuroinflammation as signaling pathways closely related

to brain diseases. The selection of these markers was based on our clinical data obtained from patients and recorded high

specificity and sensitivity when analyzed using Receiver Operating Characteristics (ROC) and excellent predictive values using

predictiveness curves. Modeling of neurological disorders in general, can help in testing the protective or therapeutic efficacy

of many selected supplements as beta lactam, bee pollen, prebiotic, probiotic, and other natural products as treatment options

that are effective in restoring the normal healthy gut microbiota.

Biography

Afaf El Ansary is a Biochemist, graduated from Biochemistry Department, Ain Shams University, Egypt in 1974. She worked in the National Research Centre, Egypt from

1976-2000, from 2001-2015. She works as a Teaching Staff Member in Biochemistry Department, King Saud University, KSA. Since 2016, she is working as Senior Scien-

tist in the central laboratory, KSU. She was recognized by the Marquis Who's Who in science and engineering, 8th edition, 2005-2006. She is Member in number of national

and international societies and she is recorded as reviewer and Editorial Board Member in many international journals. In recent years she focused on the screening of

biochemical markers related to autism with special attention to the role of gut-brain axis and she got more than 100 published papers in high impact factor journals related

to this research interest. She is Member in Predictive, Preventive and Personalized Medicine Society (Moscow).

elansary@ksu.edu.sa

Afaf El Ansary

King Saud University, Saudi Arabia

Afaf El Ansary, J Gastrointest Dig Syst 2017, 7:6(Suppl)

DOI: 10.4172/2161-069X-C1-057